A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2018
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 23 Oct 2018 Status changed from active, no longer recruiting to completed.
- 02 Aug 2018 Planned End Date changed from 1 Jul 2018 to 1 Aug 2018.
- 02 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Aug 2018.